Related Experiment Video
Updated: Jun 15, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Multiple common variants for celiac disease influencing immune gene expression
Patrick C A Dubois1, Gosia Trynka, Lude Franke
1Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Nature Genetics
|March 2, 2010
Summary
This genome-wide association study identified 13 new genetic regions linked to celiac disease risk. These findings advance our understanding of the genetic underpinnings of this immune-mediated condition.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Celiac disease is an immune-mediated disorder triggered by gluten ingestion.
- The genetic architecture of celiac disease involves numerous susceptibility loci.
- Previous genome-wide association studies (GWAS) have identified several genetic risk factors.
Purpose of the Study:
- To conduct a large-scale, second-generation GWAS to identify novel genetic risk loci for celiac disease.
- To investigate the functional relevance of identified risk variants through gene expression analysis.
Main Methods:
- Performed a two-stage GWAS including over 10,000 cases and 16,000 controls.
- Genotyped selected single nucleotide polymorphisms (SNPs) and known celiac disease loci.
- Conducted an expression quantitative trait meta-analysis on whole blood samples.
Main Results:
- Identified 13 novel genomic regions associated with genome-wide significance (P < 5 x 10(-8)).
- Many identified genes (e.g., BACH2, ETS1, RUNX3) are involved in immune function and T-cell selection.
- Found significant correlations between celiac risk variants and cis gene expression in 52.6% of tested loci.
Conclusions:
- This study significantly expands the number of known genetic loci associated with celiac disease.
- Identified genes highlight the critical role of immune pathways, particularly T-cell regulation, in celiac disease pathogenesis.
- Genetic risk variants are associated with altered gene expression, providing insights into molecular mechanisms.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...